Phani Krishna Parcha

Phani Krishna Parcha,

Postdoctoral Associate

Department: Pharmacotherapy & Translational Research
Business Phone: (434) 466-2150
Business Email: phanikrishparcha@ufl.edu

On This Page

Publications

Academic Articles

  1. Genome-wide CRISPR/Cas9 screen identifies AraC-daunorubicin-etoposide response modulators associated with outcomes in pediatric AML.

    Journal
    Blood advances.
    Volume/Issue
    9(5):1078-1091
    [DOI]
    10.1182/bloodadvances.2024014157.
    [PMID]
    39715471.
  2. Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia

    Journal
    Clinical Cancer Research.
    Volume/Issue
    30(19):4388-4396
    [DOI]
    10.1158/1078-0432.ccr-24-0863.
  3. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.

    Journal
    JAMA network open.
    Volume/Issue
    7(5)
    [DOI]
    10.1001/jamanetworkopen.2024.11726.
    [PMID]
    38753328.
  4. Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.

    Journal
    Pharmacological reports : PR.
    Volume/Issue
    73(2):615-628
    [DOI]
    10.1007/s43440-020-00196-x.
    [PMID]
    33389727.
  5. CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6.

    Journal
    Medical oncology (Northwood, London, England).
    Volume/Issue
    37(8)
    [DOI]
    10.1007/s12032-020-01395-5.
    [PMID]
    32710193.
  6. Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia.

    Journal
    Chemical biology & drug design.
    Volume/Issue
    90(4):596-608
    [DOI]
    10.1111/cbdd.12983.
    [PMID]
    28338290.

Contact Details

Phones:
Business:
(434) 466-2150
Emails:
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610
Business Street:
1225 CENTER DR
GAINESVILLE FL 32610